Benchling announced Benchling Biologics, an end-to-end platform for antibody R&D, today at the PEGS Boston Summit. Scientists ...

The $900 million life sciences cloud startup Benchling launched a new product called Benchling Validated Cloud. Scientists can use Benchling's product for research and regulatory compliance, including ...

Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...

SAN FRANCISCO, June 11, 2024 /PRNewswire/ -- Benchling, the R&D Cloud powering the biotech industry, today announced that global pharmaceutical company Sanofi is using Benchling across more than 1,500 ...

After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...

Climax Foods ramps up its ingredient discovery through its partnership with Benchling, an AI-driven data platform, which scours over 300,000 edible plant varieties to determine ingredients that offer ...

Benchling’s unicorn status didn’t come overnight. Some 10 years after its founding, the company is worth more than $6 billion, and the founder sees the company going public in the future. The ...